leadf
logo-loader
viewGenedrive PLC

Genedrive's David Budd details launch of its unique coronavirus test kits and plans for first sales

Genedrive PLC's (LON:GDR) David Budd recaps on its two coronavirus test kits. The first, which was CE marked last week and they're in the process of launching, is a high-throughput lab-based PCR test which assesses whether someone's got an active infection. The second is a point-of-care version of the test which can be done outside of hospitals. Budd also discusses WHO approval received for its HCV test as well as new distribution arrangements for its infant deafness test.

Quick facts: Genedrive PLC

Price: 40.5 GBX

AIM:GDR
Market: AIM
Market Cap: £25.59 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Genedrive PLC named herein, including the promotion by the Company of Genedrive PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Market Report: FTSE jumps higher and London stands still as UK capital...

FTSE 100 started on the front foot even though London has now entered the toughest tier of restrictions while the inflation rate plummeted in November. The UK’s leading index jumped 66 points to 6,580 in early deals. UK inflation was 0.3% in November, down from 0.7% in October following...

on 16/12/20

2 min read